To conduct a literature review on current conservative Peyronie’s disease therapy options (PD). In either the acute or chronic phases of Parkinson’s disease, conservative treatment with intralesional collagenase clostridium histolyticum (CCH) is safe and effective. Treatment combined with penile traction therapy (PTT) might yield even greater outcomes. While conventional PTT devices require up to 8 hours of therapy each day, the RestoreX® device can be effective at 30–90 minutes every day.

For the treatment of Parkinson’s disease, a number of conservative treatments are available. Oral treatments do not appear to be beneficial in terms of therapy, according to the current evidence. The predominant conservative treatment for Parkinson’s disease is intralesional therapy. Intralesional CCH treatment was the first FDA-approved intralesional therapy, and it reflects the authors’ preference for medical care. The most successful conservative management of Parkinson’s disease will almost certainly need a mix of medications.